Advertisement Β· 728 Γ— 90
#
Hashtag
#BiotechBoom
Advertisement Β· 728 Γ— 90

πŸš€ Exciting times for #CDTX! After a 105% surge from Merck's $9.2B acquisition, it's trading at $219.35. Despite overbought RSI, the bullish MACD hints at more gains. Consider a short-term long if it stays above $215. Target: $225/$230, Stop: $210. πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #INTS! With promising Phase 1/2 trial results for INT230-6, the stock is surging! πŸ“ˆ Bullish trend confirmed as price stays above 8-day EMA. Watch out for RSI nearing overbought. Consider entry at $0.68, target $0.78 & $0.85. Stay vigilant! #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #PPBT! With strong bullish momentum from promising phase 3 cancer trial results and potential big pharma partnerships, the stock is trending above key moving averages. πŸ“ˆ Consider a long position at $0.90 with targets at $1.00 & $1.10. #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #PPBT! Bullish momentum is surging after successful Phase 3 cancer trial results. πŸ“ˆ With strong upward pressure and positive MACD, consider a long position at $0.98. Targets: $1.10 & $1.20. Stop loss: $0.90. Stay sharp, volatility ahead! #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #INTS! Trading volume is soaring, and the stock has jumped from $0.27 to $0.87, fueled by buzz around its cancer therapies. With RSI nearing overbought and MACD hinting bullish, consider entering at $0.85. Targets: $1.00 & $1.20. Stop loss: $0.70. πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Excitement is building around #NERV as it surges 160% after securing $200M for its Phase 3 trial! With bullish momentum and a current price of $4.65, traders eye targets of $5.00 & $5.50. Stay sharpβ€”biotech's a wild ride! πŸ“ˆ #BiotechBoom #FeetrAI

0 0 0 0

πŸš€ Exciting times for #RANI! Bullish momentum is building after a successful phase 2 trial and whispers of a big pharma partnership. With strong technicals, consider a long position at $2.10. Targets: $2.30 & $2.50. Stop loss: $1.90. Stay tuned for updates! πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Big moves for #MIRA! After a 69% after-hours surge, MIRA's non-psychotropic cannabis compound Mira-55 outshines morphine in trials. With bullish momentum and key levels in play, consider a LONG at $1.60, targeting $1.80 & $2.00. Stay sharp on news updates! πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #GNPX! Trading at $0.66, it's riding high on positive lung cancer drug trial news. Bullish indicators and strong buying pressure suggest a potential breakout. Targeting $0.75 & $0.85 with a stop loss at $0.60. Stay tuned for updates! πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #SPRB! With FDA breakthrough status, it's surging at $159.01! πŸ“ˆ Strong bullish momentum but watch out for volatility. Consider entering at $155, targeting $175 & $190. Stop loss at $145. Stay sharp, biotech's a wild ride! #FeetrAI #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #TNYA! With strong upward momentum and a bullish MACD, Tenaya Therapeutics is breaking out above key moving averages. Targeting $1.75 & $1.85, with a stop loss at $1.55. Biotech trends could fuel the rally! πŸ“ˆ #FeetrAI #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #CGTX! Trading at $2.44, a $30M direct offering fuels growth and drug pipeline advancements. Bullish momentum with 10-day SMA at $2.40 & 8-day EMA at $2.47. Consider entering at $2.40, targeting $2.60 & $2.80. Stop loss: $2.20. #BiotechBoom πŸ“ˆ

0 0 0 0

πŸš€ Exciting times for #ALLR! Trading at $1.55 with bullish momentum and an RSI over 70, this stock is riding high on positive sentiment from its FDA Fast Track for Stenoparib. Targeting $1.80-$2.00, but watch for volatility. πŸ“ˆ #FeetrAI #StockMarket #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #ALLR! Trading at $1.55 with bullish momentum and an RSI over 70, thanks to FDA Fast Track news! πŸ“ˆ Consider entering at $1.52, targeting $1.75 & $2.00. Set a stop loss at $1.40. Stay alert for updates! #FeetrAI #StockMarket #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #CGTX! After a $30M boost for Phase 3 drug programs, investor confidence is soaring. With bullish technicals and a price above key averages, it's primed for growth. Consider entering at $2.50 with targets at $2.70 & $2.90. Manage risk wisely! πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #ASBP! Trading at $0.5197, Aspire Biopharma shows bullish momentum with strong technicals: 8-day EMA at $0.4863 & RSI at 65.9. Volume spikes hint at investor interest in their aspirin trials. Consider a LONG position targeting $0.55 & $0.58. πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #EQ! With a surge in volume and price, Equillium is riding the biotech wave 🌊. Trading above key averages with bullish MACD, but watch out for overbought RSI. Consider entry at $0.92, targeting $1.05 & $1.15. Stay alert for news! πŸ“ˆ #BiotechBoom

0 0 0 0
Der Markt fΓΌr Gentherapien auf Basis von Adeno-assoziierten Viren (AAV-Vektoren) soll bis 2034 um 56,23 Milliarden US-Dollar wachsen und eine florierende jΓ€hrliche Wachstumsrate von 25,68% erreichen. ... MarktΓΌbersicht fΓΌr AAV-Vektor‑basierte Gentherapie:Marktforschungsbericht zum Markt fΓΌr Gentherapien auf AAV-Vektorbasis nach Therapiegebiet (Erbkrankheiten, onkologische Indikationen, ophthalmologisc...

AAV-Gentherapien
πŸ§¬πŸ’‘ Gentherapie mit AAV – +$56.23 Mrd. Wachstum bis 2034 πŸ“ˆ +25.68% CAGR πŸ’₯
#GeneTherapy #BiotechBoom #FutureMedicine

ekz-crosstour.ch/2025/07/17/d...

1 0 0 0
Biologic Therapeutic Drugs Technologies Market Size, Growth Drivers and Global Forecast 2032 | At a Thriving CAGR of 7.05% - Industry Today Biologic Therapeutic Drugs Technologies Market Industry is expected to grow from 281.17(USD Billion) in 2024 to 485.0 (USD Billion) by 2032.

Biologic Therapeutic Drugs Technologies Market – Revolutionizing medicine with cutting-edge biologics! πŸ’‰πŸŒ Skyrocketing growth at 7.05% CAGR till 2032! πŸš€ #BiotechBoom #PharmaTrends #HealthcareInnovation

industrytoday.co.uk/health_and_s...

1 0 0 0
Customized Peptide Synthesis Market Set to Reach USD 13.5 Billion by 2032, with 3.62% CAGR - Industry Today Customized Peptide Synthesis Market Valued at USD 10.15 billion in 2024, the market is expected to reach USD 13.5 billion by 2032

πŸ§ͺπŸ”¬ Customized Peptide Synthesis Market to rise to $13.5B by 2032! Personalized science in action.
πŸ‘‰ #PeptideTherapy #BiotechBoom #CustomMedicine 🧫πŸ’₯

industrytoday.co.uk/health_and_s...

1 0 0 0

πŸš€ Exciting times for #AVXL! Positive Alzheimer's trial results are sparking investor interest. With bullish technicals and room to grow, consider entering around $11.60. Target: $12.00 & $12.50. Stop loss: $11.20. Dive in, but stay cautious of market swings! #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #PMN! With a breakthrough in Alzheimer's research, ProMIS Neurosciences is on the rise. Bullish indicators and volume spikes suggest strong momentum. Consider a long position at $0.95, targeting $1.10 & $1.20. Stay sharp, manage risk! πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #AVXL! With FDA approval for its Alzheimer's drug, Anavex Life Sciences is set for a potential breakout. Trading above key moving averages with bullish momentum, it's a hot pick! Entry: $12.15, Targets: $13.00/$13.50. Stop: $11.50. πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #LCTX! Trading at $1.03, Lineage Cell Therapeutics is riding high on positive OpRegen trial results. With bullish indicators and room to grow, consider a long position targeting $1.10-$1.15. Stay sharp, as volatility adds spice! #BiotechBoom

1 0 0 0

πŸš€ Exciting times for #LCTX! Trading at $1.03, it's riding a bullish wave with strong SMA & EMA signals. RSI in the low 60s shows healthy buying pressure. With OpRegen buzz and buyout rumors, consider a long position. Targets: $1.10 & $1.15. Stop loss: $0.95. πŸ“ˆ #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #CLDI! With strong bullish momentum from promising cancer treatment results, this biotech gem is on the rise. High RSI & positive MACD hint at more gains, but watch for volatility. Consider a long position targeting $0.85-$0.95. Stay sharp! #BiotechBoom

0 0 0 0

πŸš€ Exciting times for #CLDI! With positive trial results and a new pharma partnership, the stock's on fire with high volume! πŸ”₯ Overbought RSI hints at a pullback, but bullish MACD suggests more gains. Consider going long at $0.90, targeting $1.10-$1.25. πŸ“ˆ #BiotechBoom

0 0 0 0
Biotechnology Reagents Market Size, Growth Forecast 2035 Biotechnology Reagents Market is expected to grow from 46.61(USD Billion) in 2024 to 75.6 (USD Billion) by 2035. The Biotechnology Reagents Market CAGR (growth rate) is expected to be around 4.5% duri...

🧫Fueling discovery! The #BiotechReagents market powers innovation across diagnostics, therapy, and research. πŸš€πŸ”¬
#LifeSciences #BiotechBoom #LabSupplies

www.marketresearchfuture.com/reports/biot...

1 0 0 0

πŸš€ Exciting times for #ARTL! With a recent price surge to $11.44, strong bullish momentum, and clinical trial funding on the horizon, this biotech stock is buzzing! πŸ“ˆ Consider a short-term play with entry at $11.20, targeting $12-$13. Stay sharp & watch the news! #BiotechBoom

0 0 0 0